Cargando…

Magnetic Resonance Imaging Biomarkers of Punding in Parkinson’s Disease

Punding is a rare condition triggered by dopaminergic therapy in Parkinson’s disease (PD), characterized by a complex, excessive, repetitive, and purposeless abnormal movement, and its pathogenesis remains unclear. We aimed to assess the brain structure alterations related to punding by using multip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mao, Chenglu, Zhang, Yang, Jiang, Jialiu, Qin, Ruomeng, Ye, Qing, Zhu, Xiaolei, Wu, Jiayong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605844/ https://www.ncbi.nlm.nih.gov/pubmed/37891792 http://dx.doi.org/10.3390/brainsci13101423

Ejemplares similares

Punding in Parkinson's Disease: An Update
por: Rajalingam, Rajasumi, et al.
Publicado: (2023)

Patterns of Neuropsychological Profile and Cortical Thinning in Parkinson’s Disease with Punding
por: Yoo, Han Soo, et al.
Publicado: (2015)

Compulsive Drumming Induced by Dopamine Agonists in Parkinson’s Disease: Another Aspect of Punding
por: Vitale, Carmine, et al.
Publicado: (2013)

Re-Appointment of the Administrator of the Pension Pund (Cuénoud)
Publicado: (1996)

Pension Pund - Actuarial Study as at 31.12.1991 - 01.01.1992
Publicado: (1993)

Punding following posterior cerebral artery infarction: a case report and literature review
por: Lin, Cho-I, et al.
Publicado: (2017)

Punding Behavior as a Red Flag for Dementia in a Patient With Depression: Case Report
por: Pouchon, Arnaud, et al.
Publicado: (2021)

Parkinson's disease and atypical parkinsonism: the importance of magnetic resonance imaging as a potential biomarker
por: Carrete Jr., Henrique
Publicado: (2017)

Magnetic Resonance Spectroscopy: An In Vivo Molecular Imaging Biomarker for Parkinson's Disease?
por: Ciurleo, Rosella, et al.
Publicado: (2014)

Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson’s Disease Stages?
por: Hopes, Lucie, et al.
Publicado: (2016)

Magnetic Resonance Imaging (MRI) in Parkinson’s Disease
por: Tuite, Paul J, et al.
Publicado: (2013)

Magnetic resonance imaging for the diagnosis of Parkinson’s disease
por: Heim, Beatrice, et al.
Publicado: (2017)

Brain Magnetic Resonance Imaging (MRI) as a Potential Biomarker for Parkinson’s Disease (PD)
por: Tuite, Paul
Publicado: (2017)

Application of high-field magnetic resonance imaging in Parkinson's disease
por: Qiao, Peng-Fei, et al.
Publicado: (2017)

Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson’s disease
por: Sulzer, David, et al.
Publicado: (2018)

Diagnostic value of combined magnetic resonance imaging techniques in the evaluation of Parkinson disease
por: Cao, Qing, et al.
Publicado: (2023)

Magnetic resonance imaging markers for early diagnosis of Parkinson's disease☆
por: Marino, Silvia, et al.
Publicado: (2012)

Effects of cognitive reserve proxies on cognitive function and frontoparietal control network in subjects with white matter hyperintensities: A cross‐sectional functional magnetic resonance imaging study
por: Ye, Qing, et al.
Publicado: (2022)

Proton Magnetic Resonance Spectroscopy for Diagnosis of Non-Motor Symptoms in Parkinson's Disease
por: Guan, Ji-tian, et al.
Publicado: (2022)

The role of diffusion magnetic resonance imaging in Parkinson's disease and in the differential diagnosis with atypical parkinsonism
por: de Oliveira, Romulo Varella, et al.
Publicado: (2017)

The Role of Magnetic Resonance Imaging for the Diagnosis of Atypical Parkinsonism
por: Chougar, Lydia, et al.
Publicado: (2020)

Machine Learning Models for Diagnosis of Parkinson’s Disease Using Multiple Structural Magnetic Resonance Imaging Features
por: Ya, Yang, et al.
Publicado: (2022)

Magnetic Resonance Imaging-guided Focused Ultrasound Thalamotomy for Parkinson's Disease
por: Ito, Hisashi, et al.
Publicado: (2017)

Advanced diffusion magnetic resonance imaging in patients with Alzheimer's and Parkinson's diseases
por: Kamagata, Koji, et al.
Publicado: (2020)

Fast 3 T nigral hyperintensity magnetic resonance imaging in Parkinson’s disease
por: Hernadi, Gabriella, et al.
Publicado: (2021)

Diffusion Magnetic Resonance Imaging-Based Biomarkers for Neurodegenerative Diseases
por: Kamagata, Koji, et al.
Publicado: (2021)

Reduced striatal volumes in Parkinson’s disease: a magnetic resonance imaging study
por: Pitcher, Toni L, et al.
Publicado: (2012)

Magnetic Resonance Imaging Markers for Cognitive Impairment in Parkinson’s Disease: Current View
por: Hou, Yanbing, et al.
Publicado: (2022)

Magnetic Resonance Imaging as a Biomarker for Renal Cell Carcinoma
por: Wu, Yan, et al.
Publicado: (2015)

Functional Magnetic Resonance Imaging Biomarkers Predicting Cognitive Progression in Parkinson Disease: Protocol for a Prospective Longitudinal Cohort Study
por: Hanna-Pladdy, Brenda, et al.
Publicado: (2019)

Neuromelanin magnetic resonance imaging of substantia nigra and locus coeruleus in Parkinson’s disease with freezing of gait
por: Wang, Shangpei, et al.
Publicado: (2023)

Advanced magnetic resonance imaging biomarkers of cerebral metastases
por: Mills, S.J., et al.
Publicado: (2012)

T2-weighted cardiac magnetic resonance image and myocardial biomarker in hypertrophic cardiomyopathy
por: Chen, Shi, et al.
Publicado: (2020)

Alterations of Regional Homogeneity in Parkinson’s Disease: A Resting-State Functional Magnetic Resonance Imaging (fMRI) Study
por: Zhu, Hong, et al.
Publicado: (2022)

Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy
por: Sahani, Dushyant V, et al.
Publicado: (2013)

Patellar instability: the reliability of magnetic resonance imaging measurement parameters
por: Ye, Qin, et al.
Publicado: (2019)

Substantia nigra neuromelanin magnetic resonance imaging in patients with different subtypes of Parkinson disease
por: Wang, Lu, et al.
Publicado: (2021)

Application of Functional Magnetic Resonance Imaging in the Diagnosis of Parkinson’s Disease: A Histogram Analysis
por: Shi, Dafa, et al.
Publicado: (2021)

Magnetic resonance and dopamine transporter imaging for the diagnosis of Parkinson´s disease: a narrative review
por: Otani, Rafael Tomio Vicentini, et al.
Publicado: (2022)

Quantitative Analysis of Synthetic Magnetic Resonance Imaging in Alzheimer’s Disease
por: Lou, Baohui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gcmq4qkqthpiu8l7l4n093mi8d